Rigid dinitroxide biradical compounds used as improved polarizing agents for dynamic nuclear polarization techniques
Inventors
Ouari, Olivier • Tordo, Paul • CASANO, Gilles • Rosay, Melanie • AUSSENAC, Fabien • Coperet, Christophe • Lesage, Anne • Rossini, Aaron • Emsley, Lyndon • Zagdoun, Alexandre
Assignees
Eidgenoessische Technische Hochschule Zurich ETHZ • Universite Claude Bernard Lvon 1 • Aix Marseille Universite • Centre National de la Recherche Scientifique CNRS • Ecole Normale Superieure de Lyon • Bruker Biospin SAS • Universite Claude Bernard Lyon 1
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
The present invention relates to a dinitroxide biradical compound of general formula (I): In formula (I), A is a carbon, an ammonium, or a phosphonium; each of A1 to A6 is a single bond, O, N, N(O), S, S(O), SO2, C(O), or a (C1-C4) alkyl chain; and Z1 and Z2 are selected from R1 and R2 in combination, so that there is always at least one R2 group that is substituted with R3 group. In Z1 and Z2, R1 is an H, an aryl, or a heteroaryl; R2 is an alkyl chain, an alkenyl chain, an alkynyl chain, a cycloalkyl, a heterocycloalkyl, an aryl, or a heteroaryl; and R3 is an alkyl chain, an alkenyl chain, an alkynyl chain, a cycloalkyl, a heterocycloalkyl, an aryl, a heteroaryl, an ether, an ester, or an azide. When Z1 and Z2 are combined together with the same carbon atom of the nitroxide ring to which they are bonded, they form a spirocycloalkyl or a spiroheterocycloalkyl, the spirocycloalkyl or the spiroheterocycloalkyl being substituted with R3.
Core Innovation
The invention relates to rigid dinitroxide biradical polarizing agents for dynamic nuclear polarization (DNP). The compounds are defined by a broad general formula (I) in which two nitroxide units are held by a rigid linkage, and the nitroxide ring carbon is substituted with a spirocycloalkyl or spiroheterocycloalkyl group through variables including Z1, Z2, and R groups.
In the described structures, Z1 and Z2, combined together with the same carbon atom of the nitroxide unit to which they are bound, form a spirocyclohexyl substituted with one or two groups R3. R3 is a phenyl group, optionally substituted with one or more groups R4, with R4 being a phenyl. The variables A/A1-A6, Z1/Z2, and R1/R2/R3 with optional R4 allow solubilizing, reactive, photosensitizing, and isotopic labeling groups.
Preferred embodiments identify specific polarizing agents, including TEKPol derivatives such as bPhCTbK/TEKPol, TEKPol2, and TEKPol3. Comparative efficacy data are described using DNP MAS 13C amplification factors ε versus reference bTbK, together with EPR spectra and performance tables for the TEKPol derivatives.
Claims Coverage
The independent claims cover three inventive features: a biradical compound, a method of polarization using that polarizing agent, and methods of nuclear magnetic resonance analysis, particle physics, or medical imaging in which a sample is polarized using that polarizing agent.
Rigidly linked two-nitroxide biradical with spirocyclohexyl/phenyl substitution
A biradical compound in which two nitroxide units are held by a rigid linkage, and Z1 and Z2, combined together with the same carbon atom of the nitroxide unit to which they are bound, form a spirocyclohexyl substituted with one or two groups R3, R3 being a phenyl group optionally substituted with one or more groups R4, in which R4 is a phenyl.
Polarization using the rigidly linked dinitroxide biradical polarizing agent
A method of polarization of a sample, comprising a step of bringing the sample into contact with a polarizing agent, wherein the polarizing agent is a biradical compound in which two nitroxide units are held by a rigid linkage, and Z1 and Z2 form a spirocyclohexyl substituted with one or two groups R3, R3 being a phenyl group optionally substituted with one or more groups R4, in which R4 is a phenyl.
NMR analysis, particle physics, or medical imaging by polarized sample using the defined polarizing agent
A method of nuclear magnetic resonance analysis, particle physics, or medical imaging, comprising polarization of a sample using the same defined polarizing agent.
The claim set centers on the specified dinitroxide biradical architecture with a rigid linkage and a spirocyclohexyl substitution formed by Z1 and Z2 on the nitroxide-bound carbon, where R3 is phenyl and R4 is phenyl. This polarizing agent is then used to polarize a sample for DNP-related polarization and for methods directed to nuclear magnetic resonance analysis, particle physics, or medical imaging.
Stated Advantages
Improved DNP performance is demonstrated by comparative DNP MAS 13C amplification factors ε versus reference bTbK for TEKPol derivatives.
Electron relaxation time (T1e, T2e) and molecular weight are discussed as correlating with the observed DNP performance for the TEKPol derivatives.
Documented Applications
NMR using polarized samples, including DNP (e.g., DNP MAS 13C) for solids and other NMR contexts described in the document.
Particle physics applications, where the method includes polarization of a sample using the defined polarizing agent.
Medical imaging applications, where the method includes polarization of a sample using the defined polarizing agent.
Interested in licensing this patent?